Research Overview Understanding BPC-157 BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide whose 15-amino-acid sequence was derived from a larger gastric protective protein first characterised by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s
Potential endpoints include: Collagen-associated gene expression Collagen-associated protein measurements Elastin-associated variables Fibronectin measurements Matrix metalloproteinase activity Tissue inhibitor measurements Matrix deposition Three-dimensional structural imaging Changes in extracellular-matrix markers do not independently establish skin repair, wound healing, scar reduction, increased elasticity, or cosmetic improvement
AD patients also display additional biomarkers including cerebrovascular pathology and vascular dysfunctions, decreases in cerebral blood flow, cerebrovascular reactivity, and neurovascular coupling, leading to brain deficits in oxygen and nutrient delivery [4,5]
Metabolic Studies of a Synthetic Lipolytic Domain AOD9604 of Human Growth Hormone Hormone Research (2000) 7
Lipo-C Shot: Supports tissue repair, metabolism, and fat mobilization